The diagnosis and treatment of toxoplasmosis.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000906:Antibodies / Q000032:analysis; D000941:Antigens / Q000032:analysis; D002648:Child; D005260:Female; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D008403:Mass Screening; D011247:Pregnancy; D011739:Pyrimethamine / Q000627:therapeutic use; D012698:Serologic Tests; D013411:Sulfadiazine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology / Q000517:prevention & control; D014125:Toxoplasmosis, Congenital / Q000276:immunology; D014126:Toxoplasmosis, Ocular / Q000276:immunology
D000900:Anti-Bacterial Agents; D000906:Antibodies; D000941:Antigens; D013411:Sulfadiazine; D011739:Pyrimethamine